Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study
The programmed death receptor 1 (PD1) and its ligand programmed death receptor ligand 1 (PDL1) are the most widely used immune checkpoints in cancer immunotherapy. The related literature shows the explosive growth trends due to the promising outcomes of tumor regression. The present study aimed to p...
Saved in:
Main Authors: | Yiting Sun (Author), Liqing Jiang (Author), Ti Wen (Author), Xiaoyu Guo (Author), Xinye Shao (Author), Hui Qu (Author), Xi Chen (Author), Yujia Song (Author), Fang Wang (Author), Xiujuan Qu (Author), Zhi Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Fluzoparib for multiple lines of chemotherapy refractory in metastatic cutaneous squamous cell carcinoma with BRCA2 pathogenic mutation
by: Xin Sun, et al.
Published: (2022) -
The mechanisms of natural products for eye disorders by targeting mitochondrial dysfunction
by: Gui-Feng Sun, et al.
Published: (2024) -
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
by: Xiaoyu Zhang, et al.
Published: (2020) -
Erigeron breviscapus (Vant.) Hand-Mazz.: A Promising Natural Neuroprotective Agent for Alzheimer's Disease
by: Xiaoyu Dong, et al.
Published: (2022) -
IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?
by: Yufeng Xi, et al.
Published: (2022)